ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in ADC Therapeutics SA as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- −4 vs. Q1 2026
- Shares held
- 80.7M
- −2.76M (−3.3%) vs. Q1 2026
- Total value
- $86.3M
- −$226.5M (−72.4%) vs. Q1 2026
- New holders
- 26
- 42 more added
- Sold out
- 30
- 30 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $86.3M |
| Q1 2026 | 118 | $312.9M |
| Q4 2025 | 115 | $292.8M |
| Q3 2025 | 106 | $271.3M |
| Q2 2025 | 86 | $182.1M |
| Q1 2025 | 82 | $77.3M |
| Q4 2024 | 83 | $112.4M |
| Q3 2024 | 77 | $172.9M |
| Q2 2024 | 74 | $163.7M |
| Q1 2024 | 37 | $155.8M |
| Q4 2023 | 38 | $56.4M |
| Q3 2023 | 41 | $35.4M |
| Q2 2023 | 56 | $97.5M |
| Q1 2023 | 59 | $90.9M |
| Q4 2022 | 60 | $149.1M |
| Q3 2022 | 66 | $176.5M |
| Q2 2022 | 58 | $274.1M |
| Q1 2022 | 49 | $501.3M |
| Q4 2021 | 55 | $682.8M |
| Q3 2021 | 53 | $890.6M |
| Q2 2021 | 56 | $816.3M |
| Q1 2021 | 59 | $801.3M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding ADC Therapeutics SA; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 1,445,546 | $1.55M | 0.00% | +241,790+20.1% | Added |
| State Street Corp | 1,685,836 | $1.80M | 0.00% | +119,174+7.6% | Added |
| Goldman Sachs Group Inc | 1,914,424 | $2.05M | 0.00% | +261,398+15.8% | Added |
| Citadel Advisors LLC | 2,053,316 | $2.20M | 0.00% | +1,653,595+413.7% | Added |
| Millennium Management LLC | 2,899,535 | $3.10M | 0.00% | −219,619−7.0% | Reduced |
| Morgan Stanley | 3,051,173 | $3.26M | 0.00% | −761,409−20.0% | Reduced |
| Point72 Asset Management, L.P. | 3,649,144 | $3.90M | 0.01% | +267,015+7.9% | Added |
| BlackRock, Inc. | 7,020,093 | $7.51M | 0.00% | +769,346+12.3% | Added |
| Prosight Management, LP | 7,824,749 | $8.37M | 1.44% | −475,251−5.7% | Reduced |
| TCG Crossover Management, LLC | 11,390,175 | $12.2M | 0.29% | 00.0% | Unchanged |
| Redmile Group, LLC | 11,526,710 | $12.3M | 0.83% | −3,943,792−25.5% | Reduced |
| Nantahala Capital Management, LLC | 12,326,184 | $13.2M | 0.80% | +6,728,751+120.2% | Added |
| Alliancebernstein L.P. | 108,470 | – | – | +66,620+159.2% | Added |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −5,701,655−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,318,026−100.0% | Sold out |
| Voleon Capital Management LP | 0 | $0 | 0.00% | −513,831−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −299,278−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −262,595−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −156,126−100.0% | Sold out |
| Kingswood Wealth Advisors, LLC | 0 | $0 | 0.00% | −105,107−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −77,947−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −77,390−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −76,268−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −53,690−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −45,479−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −43,970−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −32,230−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −31,593−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −25,826−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −22,442−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −19,280−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −17,395−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −16,718−100.0% | Sold out |
| Quantinno Capital Management LP | 0 | $0 | 0.00% | −14,719−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −11,755−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −10,577−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −1,119−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −173−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |